🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Stanford Cancer Center at Stanford University Medical Center
Start Date
1989-04
Trial ID
NCT00002715
EBV-HLH is a rare disease with high mortality, especially for those with in...
Status
Not Yet Recruiting
Location
Zhao Wang
Start Date
2023-12-01
Trial ID
NCT06131489
Treatments Being Tested
A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with B...
Status
Recruiting
Location
Institut Català D'Oncologia - Hospital Germans Trias I Pujol
Start Date
2020-06-01
Trial ID
NCT04378647
This study is a Phase 3, global, multi-center, open-label study of patients...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2006-08
Trial ID
NCT00363415
Treatments Being Tested
It is expected that addition of anti-CD20 antibody - ofatumumab would enhan...
Status
Completed
Location
Dolnośląskie Centrum Transplantacji Komórkowych
Start Date
2011-11
Trial ID
NCT01481272
The purpose of this study is to assess whether patients who are likely to f...
Status
Unknown
Location
BC Cancer Agency
Start Date
2006-08
Trial ID
NCT00324467
This clinical trial is for men and women with whose lymphoma (non-Hodgkin o...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2014-06-04
Trial ID
NCT02059239
To explore the safety, tolerability, and clinical effects of decitabine com...
Status
Unknown
Location
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Start Date
2018-06-01
Trial ID
NCT03558412
Treatments Being Tested
Addition of nivolumab (immune checkpoint inhibitor) to standard chemotherap...
Status
Enrolling By Invitation
Location
Dmitry Rogachev National Research Center
Start Date
2024-09-01
Trial ID
NCT06871007
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of lurbine...
Status
Recruiting
Location
Valkyrie Clinical Trials, Inc.
Start Date
2026-08-30
Trial ID
NCT07459634
Treatments Being Tested